Marlene Hager

Dec 20, 2024 | mdpi.com | Marlene Hager

Article Menu /ajax/scifeed/subscribe Altmetric announcement Help format_quote Cite thumb_up ... Endorse Need Help? Find support for a specific problem in the support section of our website. Please let us know what you think of our products and services. Visit our dedicated information section to learn more about MDPI.

Jun 13, 2024 | tandfonline.com | Marlene Hager |Victoria Fitz |Johannes Ott |Tal Goldstein

ABSTRACTIntroduction In many postmenopausal women, quality of life is decreased due to vasomotor symptoms. Efficient and well-tolerated non-hormonal treatment options are needed. Areas covered The present review summarizes what is known about the etiology of postmenopausal vasomotor symptoms as a rationale for the mechanism of action of Elinzanetant, a new neurokinin (NK)-1/-3 receptor antagonist, as well as its efficacy and side effect profile.